Medical Condition News

RSS

Accuray to present CyberKnife Robotic Radiosurgery System at ASTRO Meeting

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that 40 accepted abstracts highlighting the use of the CyberKnife Robotic Radiosurgery System will be presented as posters and presentations at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO), taking place in San Diego from October 31-November 4.

30 Oct 2010

Study finds SBRT therapy delays pancreatic cancer progression

For pancreatic cancer patients unable to undergo surgery the only known cure for this form of cancer a highly targeted cancer radiation therapy may help slow cancer progression and lessen disease symptoms, according to researchers at Henry Ford Hospital in Detroit.

30 Oct 2010

AACR announces launch of new journal, Cancer Discovery

The American Association for Cancer Research announces the launch of its newest journal, Cancer Discovery, which will publish high-impact, peer-reviewed articles describing major advances in basic and clinical research. Its unique format will feature game-changing research, review articles, perspectives and commentaries, news, and "Research Watch" summaries of important journal articles. Cancer Discovery is a new addition to the AACR's robust publication program.

30 Oct 2010

Tryton Side Branch Stent System offers new treatment strategy for atherosclerotic lesions

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced interim six-month results from the company's E-Tryton registry evaluating the TRYTON Side Branch Stent System at 15 European sites.

30 Oct 2010

CPRIT awards cancer research grants to 13 Texas institutions

The Cancer Prevention and Research Institute of Texas (CPRIT), the second largest funding source of cancer research in the United States, kicks off its second year by awarding 52 cancer research grants totaling $40,302,026 to 13 Texas institutions. Among the grants are two CPRIT Scholars in Cancer Research recruitment awards bringing outstanding scientists from preeminent institutions to join the faculty at Texas universities.

30 Oct 2010

Alnylam to present data on RNAi therapeutics for fibrotic diseases at The Liver Meeting

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it will present several poster presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases being held in Boston, Mass from October 29 - November 2, 2010.

30 Oct 2010

Advaxis enters CRADA with NCI for development of live attenuated Listeria vaccines

Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, is pleased to announce it has signed a formal research agreement with the National Cancer Institute at the National Institutes of Health.

30 Oct 2010

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

An endocrinologist in the University at Buffalo's School of Medicine and Biomedical Sciences has received a three-year $400,000 Junior Faculty Award from the American Diabetes Society to study the effects of low testosterone levels in young men with type 2 diabetes.

30 Oct 2010

Dysfunction of Grhl2 factor may affect epithelial barrier formation, contribute to congenital abnormalities

Scientists of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and the Experimental and Clinical Research Center (ECRC) of MDC and Charit- in Berlin-Buch have gained new insights into the development of epithelial cells and their molecular repertoire.

30 Oct 2010

APP receives FDA marketing approval for Metoprolol Tartrate Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Metoprolol Tartrate Injection, USP, and expects to launch the medication soon.

30 Oct 2010

OHSU to lead next phase of HuCNS-SC trial for NCL in children

Oregon Health & Science University Doernbecher Children's Hospital will lead the next phase of a landmark clinical trial to further assess the safety and preliminary effectiveness of purified human neural stem cells (HuCNS-SC-) as a potential treatment for infantile or late-infantile neuronal ceroid lipofuscinosis (NCL), a rare and currently fatal neurodegenerative disorder that affects infants and children.

30 Oct 2010

FDA approves NUEDEXTA capsules for pseudobulbar affect

AVANIR Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate) capsules, as the first treatment for pseudobulbar affect.

30 Oct 2010

Study suggests curcumin may be an effective therapy for liver fibrosis

Curcumin, a chemical that gives curry its zing, holds promise in preventing or treating liver damage from an advanced form of a condition known as fatty liver disease, new Saint Louis University research suggests.

30 Oct 2010

CSL Behring creates Interlaken Leadership Awards to support innovative immunoglobulin research

To demonstrate its continued commitment to innovative immunoglobulin (Ig) research, CSL Behring announced today it has created the Interlaken Leadership Awards. This global awards program will provide monetary grants to advance medical research and knowledge about the potential role of immunoglobulin therapy in the treatment of neurologic disorders.

29 Oct 2010

CURE Foundation orders for five Varian TrueBeam stereotactic radiosurgery and radiation therapy systems

Varian Medical Systems, Inc. today announced that CURE Foundation has placed an order for five Varian TrueBeam™ systems for stereotactic radiosurgery and radiation therapy.

29 Oct 2010

Cipher completes enrolment in CIP-ISOTRETINOIN Phase III study for severe, nodular acne

Cipher Pharmaceuticals Inc. today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under a Special Protocol Assessment that was granted by the U.S. Food and Drug Administration (FDA).

29 Oct 2010

New Chicago Sports Concussion Clinic at Rush University provides proper diagnosis for athletes

Concussions, like any injury, need proper assessment and time to heal. Some may brush off an injury to the head, but an injury to the brain may be severe with possible long-term consequences. Athletes or individuals who suffer a bump or blow to the head now can see a physician for assessment within 24 to 48 hours at the new Chicago Sports Concussion Clinic at Rush University Medical Center.

29 Oct 2010

MAP Pharmaceuticals to present FREEDOM-301 Phase 3 trial data for migraine at EHMTIC Congress

MAP Pharmaceuticals, Inc. today announced new data from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX orally inhaled migraine therapy showing low recurrence rates with LEVADEX. Eight additional analyses from the LEVADEX program also will be presented during the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.

29 Oct 2010

Compugen signs oncology research collaboration agreement with Seattle Genetics

Compugen Ltd. announced today that it has signed a research collaboration agreement with Seattle Genetics, Inc., USA, covering a Compugen-discovered oncology target. The agreement provides Seattle Genetics with an initial evaluation period and an option for an exclusive worldwide milestone and royalty bearing license for development and commercialization of monoclonal antibody therapeutics addressing this novel target.

29 Oct 2010

Study suggests microRNA binding site helps improved prognosis of colorectal cancer at early stage

A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.

29 Oct 2010

Medical Condition News

Accuray to present CyberKnife Robotic Radiosurgery System at ASTRO Meeting

Study finds SBRT therapy delays pancreatic cancer progression

AACR announces launch of new journal, Cancer Discovery

Tryton Side Branch Stent System offers new treatment strategy for atherosclerotic lesions

CPRIT awards cancer research grants to 13 Texas institutions

Alnylam to present data on RNAi therapeutics for fibrotic diseases at The Liver Meeting

Advaxis enters CRADA with NCI for development of live attenuated Listeria vaccines

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

Dysfunction of Grhl2 factor may affect epithelial barrier formation, contribute to congenital abnormalities

APP receives FDA marketing approval for Metoprolol Tartrate Injection

OHSU to lead next phase of HuCNS-SC trial for NCL in children

FDA approves NUEDEXTA capsules for pseudobulbar affect

Study suggests curcumin may be an effective therapy for liver fibrosis

CSL Behring creates Interlaken Leadership Awards to support innovative immunoglobulin research

CURE Foundation orders for five Varian TrueBeam stereotactic radiosurgery and radiation therapy systems

Cipher completes enrolment in CIP-ISOTRETINOIN Phase III study for severe, nodular acne

New Chicago Sports Concussion Clinic at Rush University provides proper diagnosis for athletes

MAP Pharmaceuticals to present FREEDOM-301 Phase 3 trial data for migraine at EHMTIC Congress

Compugen signs oncology research collaboration agreement with Seattle Genetics

Study suggests microRNA binding site helps improved prognosis of colorectal cancer at early stage

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News